Design Therapeutics Ratios (2020-2021) | DSGN

Ratios Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021
Profitability
EBT Margin -438.73%-4,719.35%-11,915.00%-11,700.00%
EBIT Margin -438.73%-4,719.35%-11,915.00%-11,700.00%
EBITDA Margin -438.73%-4,719.35%-11,915.00%-11,700.00%
Operating Margin -438.73%-4,719.35%-11,915.00%-11,700.00%
Net Margin -438.73%-4,719.35%-11,915.00%-11,700.00%
FCF Margin -1,872.54%-4,216.13%-9,295.00%-8,660.61%
Efficiency
Assets Average 224.19M408.50M402.75M
Equity Average 198.35M404.80M396.58M
Invested Capital -11.31M408.01M401.60M391.56M
Leverage & Solvency
Equity Ratio -0.310.990.990.98
Valuation
Enterprise Value -36.09M1,197.80M703.39M423.30M
Market Capitalization 1,609.14M1,106.23M817.02M
Return Ratios
Return on Sales -36.86%